Intranasal delivery of ACE2‐(G4S)6‐Fc conferred highly effective suppression of SARS‐CoV‐2 in the nasal turbinates of hamsters, the key site for virus replication and dissemination, even when treatment was withheld until 48 h after infection. Here, ACE2 is linked to infection.